Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Obstetrics and Gynecology
Volume 2017, Article ID 5175629, 5 pages
https://doi.org/10.1155/2017/5175629
Case Report

Undetected Severe Fetal Myelosuppression following Administration of High-Dose Cytarabine for Acute Myeloid Leukemia: Is More Frequent Surveillance Necessary?

Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Kansas School of Medicine, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA

Correspondence should be addressed to Jessica Parrott; ude.cmuk@3ttorrapj

Received 20 June 2017; Revised 14 August 2017; Accepted 17 August 2017; Published 17 September 2017

Academic Editor: Erich Cosmi

Copyright © 2017 Jessica Parrott and Marium Holland. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Jessica Parrott and Marium Holland, “Undetected Severe Fetal Myelosuppression following Administration of High-Dose Cytarabine for Acute Myeloid Leukemia: Is More Frequent Surveillance Necessary?,” Case Reports in Obstetrics and Gynecology, vol. 2017, Article ID 5175629, 5 pages, 2017. https://doi.org/10.1155/2017/5175629.